JCOG

The Japan Clinical Oncology Group (JCOG) is the largest Japanese cooperative group funded primarily by the National Cancer Center Research and Development Fund.

HNCSG:Head and Neck Cancer Study Group / Publications

更新日:2013年11月8日

a. 論文

1. 委員会承認の治療研究

K Nakamura, M Tahara, N Kiyota, et al.: Phase II trial of concurrent chemoradiotherapy with S-1 plus cisplatin in patients with unresectable locally advanced squamous cell carcinoma of the head and neck: Japan Clinical Oncology Group Study (JCOG0706). Jpn J Clin Oncol. 39:460-463, 2009.

2. グループ代表者管理の治療研究

M Fujii, K Tomita, W Nishijima, et al.: Phase I/II study of S-1 plus ciaplatin combination chemotherapy in patients with advanced/recurrent head and neck cancer. Jpn J Clin Oncol. 40: 214-221, 2010.
M Tahara, H Minami, M Kawashima, et al.: Phase I trial of chemoradiotherapy with the combination of S-1 plus cisplatin for patients with unresectable locally advanced squamous cell carcinoma of the head and neck. Cancer Sci. 102(2): 419-424, 2011.
M Tahara, K Araki, S Okano, et al.: Phase I trial of combination chemotherapy with docetaxel, cisplatin and S-1 (TPS) in patients with locally advanced or recurrent/metastatic head and neck cancer. Ann Oncol. 22(1): 175-180, 2011.
N Kiyota, M Tahara, S Okano, et al.: Phase II feasibility trial of adjuvant chemoradiotherapy with 3-weekly cisplatin for Japanese patients with post-operative high-risk squamous cell carcinoma of the head and neck. Jpn J Clin Oncol. 42 (10): 927-933, 2012.
S Kano, A Homma, R Hayashi, et al.: Salvage surgery for recurrent oropharyngeal cancer after chemoradiotherapy. Int J Clin Oncol. E-pub 2012.
S Kano, A Homma, R Hayashi, et al.: Matched-pair analysis in patients with advanced oropharyngeal cancer: surgery versus concurrent chemoradiotherapy. Oncology 84(5) 290-298, 2013.

3. 附随研究等

なし  

4. 総説・解説

藤井正人:頭頸部癌に対する薬物療法の進歩 日本耳鼻咽喉科学会会報116, 767-778, 2013.

b. 主な学会発表

1. 委員会承認の治療研究

M Tahara, N Kiyota, J Mizusawa, et al.: Phase II trial of chemoradiotherapy concurrent with S-1 plus cisplatin in patients with unresectable locally advanced squamous cell carcinoma of the head and neck (SCCHN): results of the Japan Clinical Oncology Group study, JCOG 0706. 48th Annual meeting of the American Society of Clinical Oncology. Proc Am Soc Clin Oncol.30: abstr 5542, Jun 2012.

2. グループ代表者管理の治療研究

なし  

3. 附随研究等

なし  

4. 総説・解説

なし